Study of Safety, Tolerability, and Efficacy of Ustekinumab for Symptomatic Gastrointestinal Inflammation Associated With Common Variable Immunodeficiency
Clinical trial NCT02199496 · COMPLETED
Trial details
- NCT number
- NCT02199496
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-19
- Primary completion
- 2019-08-16
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.